Pfizer’s CEO makes big play with $68B Wyeth deal (AP)

In this Sept. 23, 2008 file photo, Jeff Kindler, Chairman and CEO of Pfizer, speaks at the World Business Forum in New York. Pharmaceutical giant Pfizer Inc. is buying rival drugmaker Wyeth in a $68 billion cash-and-stock deal that could reshape the drug development industry.  (AP Photo/Mark Lennihan, File)AP – Jeff Kindler took over as chief executive of drugmaker Pfizer Inc. in August 2006, just in time to sign off on his predecessor’s $16.6 billion deal to sell off all its iconic consumer health brands, from Listerine to Sudafed — to become a pure pharmaceutical company.

Leave a Reply